BofA Hikes Exelixis, Inc. (EXEL) Target Amid CRC Caution
On Thursday, analysts at BofA Securities raised the price target for Exelixis, Inc. (NASDAQ:EXEL) to $46 from $45, with a Neutral rating.
Exelixis Inc. (EXEL)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 22,533,500 | $831,936,820 | -4% | 4.64% |
| 2. | Renaissance Technologies Jim Simons | 14,824,265 | $547,311,864 | -4% | 0.83% |
| 3. | AQR Capital Management Cliff Asness | 6,893,889 | $250,868,604 | +74% | 0.26% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,682,076 | $135,942,246 | +17% | 0.11% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 2,285,090 | $84,365,523 | +41% | 0.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.76 | 225,000 | $4,670,055.00 | 1,525,730 | 2024-05-30 | Filing | |
| $20.32 | 200,000 | $4,063,900.00 | 1,300,730 | 2024-05-28 | Filing | |
| $20.70 | 190,000 | $3,932,734.00 | 1,100,730 | 2024-02-21 | Filing | |
| $21.61 | 120,409 | $2,602,038.49 | 910,730 | 2023-11-27 | Filing | |
| $4.95 | 20,000 | $99,000.00 | 568,273 | 2016-05-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.67 | 4 | $174.68 | 21,380 | 2025-06-02 | Filing | |
| $42.74 | 18,834 | $804,965.16 | 21,384 | 2025-06-02 | Filing | |
| $43.09 | 7,535 | $324,683.15 | 358,882 | 2025-06-03 | Filing | |
| $44.06 | 34,387 | $1,515,091.22 | 412,072 | 2025-05-20 | Filing | |
| $44.29 | 4,544 | $201,253.76 | 32,470 | 2025-05-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 30,356,918 | $1,120,777,413 | 0.02% | |
| 2. | 28,671,987 | $1,058,569,761 | 0.02% | |
| 3. | 11,789,612 | $435,272,475 | 0.02% | |
| 4. | 7,795,074 | $287,794,122 | 1.12% | |
| 5. | 7,417,180 | $273,899,091 | 0.02% |
News See All
Exelixis, Inc. (NASDAQ:EXEL) Q1 2025 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Exelixis First Quarter 2025 Financial Results Conference Call. My name is Towanda, and I'll be your operator for today.
15 Best Stocks to Buy According to Jim Simons' Renaissance Technologies
Even after his passing in 2024, billionaire investor and mathematician Jim Simons remains known as the "Quant King" of hedge funds due to the extraordinary success of Renaissance Technologies, his quantitative...
20 Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy
Uncertainty is around every corner of the U.S. stock market, affecting investors’ decisions.
7 Most Profitable Biotech Stocks To Buy Right Now
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
10 Best Immunology Stocks To Buy Now
Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.
Renaissance Technologies Portfolio: Top 10 Stock Picks
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its investment programs.
Exelixis, Inc. (NASDAQ:EXEL) Q4 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Exelixis Fourth Quarter and Fiscal Year 2024 Financial Results Conference Call. My name is Sherry, and I'll be your operator for today.
What Makes Exelixis (EXEL) an Investment Bet?
Riverwater Partners, an investment management company, released its “Sustainable Value Strategy” Q4 2024 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
